The global demand for Neonatal Hearing Screening Devices Market is presumed to reach the market size of nearly USD 53 MN by 2028 from USD 38.95 MN in 2021 with a CAGR of 4.5% under the study period 2022 - 2028.
Neonatal hearing screening devices consist of hearing diagnostic devices and related services. Neonatal hearing screening devices are used for the treatment of loss and for evaluating hearing loss.
The factor driving the growth of the neonatal hearing screening devices market is the initiatives various organizations take to launch programs to raise awareness about newborn care, particularly hearing screening programs. Apart from this, a high risk of neonatal problems and high birth rates are also expected to fuel the market growth. Genetic issues and environmental factors, such as maternal infections during pregnancy and complications after birth, are responsible for hearing loss in newborn babies. As a result, the screening of hearing loss and hearing impairment is a must for the early diagnosis and treatment of newborns. Thus, the growing incidence of hearing loss and hearing impairment, and future complications associated with it, will drive the growth of the neonatal hearing screening devices market during the forecast period. Moreover, technological advancements in neonatal screening devices are anticipated to propel neonatal hearing screening devices' growth. Furthermore, the increasing number of neonatal intensive care units will fuel the demand for neonatal hearing screening devices. However, the lack of skilled neonatal nurses and low accessibility to advanced neonatal technologies and hearing devices are the challenging factors expected to hamper the market growth.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of neonatal hearing screening devices. The growth and trends of neonatal hearing screening devices industry provide a holistic approach to this study.
This section of the neonatal hearing screening devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product Type
- Auditory Brainstem Response (ABR) Systems
- Otoacoustic Emission (OAE) Systems
- Combination Systems
By End User
- Table Top Devices
- Trolley Mounted Devices
- Portable And Hand-Held Devices
- Specialty Clinics
This section covers the regional outlook, which accentuates current and future demand for the Neonatal Hearing Screening Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Neonatal Hearing Screening Devices Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the neonatal hearing screening devices market include Natus Medical Incorporated, Welch Allyn (Hill-Rom Inc.), Demant A/S, Path Medical GmbH, Intelligent Hearing Systems, Vivosonic Inc., Pilot Blankenfelde GmbH, Echodia SAS. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.